Cargando…
Reduction in calcium excretion in women with breast cancer and bone metastases using the oral bisphosphonate pamidronate.
The bisphosphonate pamidronate (3 amino-1, 1-hydroxypropylidene bisphosphonate (APD), Ciba-Geigy) is a powerful inhibitor of osteoclast function and has been shown to significantly reduce osteolysis associated with bone metastases in breast cancer. Until recently, however, only an intravenous prepar...
Autores principales: | Dodwell, D. J., Howell, A., Ford, J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1990
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971333/ https://www.ncbi.nlm.nih.gov/pubmed/2297483 |
Ejemplares similares
-
Bisphosphonates and bone metastases.
por: Morton, A. R., et al.
Publicado: (1988) -
The bisphosphonate pamidronate induces apoptosis in human melanoma cells in vitro
por: Riebeling, C, et al.
Publicado: (2002) -
Treatment with intravenous pamidronate is a good alternative in case of gastrointestinal side effects or contraindications for oral bisphosphonates
por: Eekman, Danielle A, et al.
Publicado: (2009) -
The effect of pamidronate delivery in bisphosphonate-naïve patients on neutrophil chemotaxis and oxidative burst
por: Chadwick, Jeffrey W., et al.
Publicado: (2020) -
Bone targeting compounds for radiotherapy and imaging: *Me(III)-DOTA conjugates of bisphosphonic acid, pamidronic acid and zoledronic acid
por: Meckel, M., et al.
Publicado: (2016)